These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 25722219)

  • 1. Laguna Negra Virus Infection Causes Hantavirus Pulmonary Syndrome in Turkish Hamsters (Mesocricetus brandti).
    Hardcastle K; Scott D; Safronetz D; Brining DL; Ebihara H; Feldmann H; LaCasse RA
    Vet Pathol; 2016 Jan; 53(1):182-9. PubMed ID: 25722219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A lethal disease model for New World hantaviruses using immunosuppressed Syrian hamsters.
    Vergote V; Laenen L; Vanmechelen B; Van Ranst M; Verbeken E; Hooper JW; Maes P
    PLoS Negl Trop Dis; 2017 Oct; 11(10):e0006042. PubMed ID: 29077702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A lethal disease model for hantavirus pulmonary syndrome.
    Hooper JW; Larsen T; Custer DM; Schmaljohn CS
    Virology; 2001 Oct; 289(1):6-14. PubMed ID: 11601912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Syrian hamster model of hantavirus pulmonary syndrome.
    Safronetz D; Ebihara H; Feldmann H; Hooper JW
    Antiviral Res; 2012 Sep; 95(3):282-92. PubMed ID: 22705798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenesis and host response in Syrian hamsters following intranasal infection with Andes virus.
    Safronetz D; Zivcec M; Lacasse R; Feldmann F; Rosenke R; Long D; Haddock E; Brining D; Gardner D; Feldmann H; Ebihara H
    PLoS Pathog; 2011 Dec; 7(12):e1002426. PubMed ID: 22194683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maporal viral infection in the Syrian golden hamster: a model of hantavirus pulmonary syndrome.
    Milazzo ML; Eyzaguirre EJ; Molina CP; Fulhorst CF
    J Infect Dis; 2002 Nov; 186(10):1390-5. PubMed ID: 12404153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A lethal disease model for hantavirus pulmonary syndrome in immunosuppressed Syrian hamsters infected with Sin Nombre virus.
    Brocato RL; Hammerbeck CD; Bell TM; Wells JB; Queen LA; Hooper JW
    J Virol; 2014 Jan; 88(2):811-9. PubMed ID: 24198421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depletion of Alveolar Macrophages Does Not Prevent Hantavirus Disease Pathogenesis in Golden Syrian Hamsters.
    Hammerbeck CD; Brocato RL; Bell TM; Schellhase CW; Mraz SR; Queen LA; Hooper JW
    J Virol; 2016 Jul; 90(14):6200-6215. PubMed ID: 27099308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T cells are not required for pathogenesis in the Syrian hamster model of hantavirus pulmonary syndrome.
    Hammerbeck CD; Hooper JW
    J Virol; 2011 Oct; 85(19):9929-44. PubMed ID: 21775442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Active and passive vaccination against hantavirus pulmonary syndrome with Andes virus M genome segment-based DNA vaccine.
    Custer DM; Thompson E; Schmaljohn CS; Ksiazek TG; Hooper JW
    J Virol; 2003 Sep; 77(18):9894-905. PubMed ID: 12941899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The adaptive immune response does not influence hantavirus disease or persistence in the Syrian hamster.
    Prescott J; Safronetz D; Haddock E; Robertson S; Scott D; Feldmann H
    Immunology; 2013 Oct; 140(2):168-78. PubMed ID: 23600567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of transcriptional responses between pathogenic and nonpathogenic hantavirus infections in Syrian hamsters using NanoString.
    Brocato RL; Altamura LA; Carey BD; Perley CC; Blancett CD; Minogue TD; Hooper JW
    PLoS Negl Trop Dis; 2021 Aug; 15(8):e0009592. PubMed ID: 34339406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hantavirus pulmonary syndrome.
    Macneil A; Nichol ST; Spiropoulou CF
    Virus Res; 2011 Dec; 162(1-2):138-47. PubMed ID: 21945215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hantavirus pulmonary syndrome is distinguishable from acute interstitial pneumonia.
    Colby TV; Zaki SR; Feddersen RM; Nolte KB
    Arch Pathol Lab Med; 2000 Oct; 124(10):1463-6. PubMed ID: 11035576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Choclo virus infection in the Syrian golden hamster.
    Eyzaguirre EJ; Milazzo ML; Koster FT; Fulhorst CF
    Am J Trop Med Hyg; 2008 Apr; 78(4):669-74. PubMed ID: 18385367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA vaccine-generated duck polyclonal antibodies as a postexposure prophylactic to prevent hantavirus pulmonary syndrome (HPS).
    Brocato R; Josleyn M; Ballantyne J; Vial P; Hooper JW
    PLoS One; 2012; 7(4):e35996. PubMed ID: 22558299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polyclonal alpaca antibodies protect against hantavirus pulmonary syndrome in a lethal Syrian hamster model.
    Sroga P; Sloan A; Warner BM; Tierney K; Lew J; Liu G; Chan M; Deschambault Y; Stein DR; Soule G; Banadyga L; Falzarano D; Safronetz D
    Sci Rep; 2021 Aug; 11(1):17440. PubMed ID: 34465819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo activity of ribavirin against Andes virus infection.
    Safronetz D; Haddock E; Feldmann F; Ebihara H; Feldmann H
    PLoS One; 2011; 6(8):e23560. PubMed ID: 21853152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of vascular and lymphatic endothelial cells in hantavirus pulmonary syndrome suggests targeted therapeutic approaches.
    Mackow ER; Gorbunova EE; Dalrymple NA; Gavrilovskaya IN
    Lymphat Res Biol; 2013 Sep; 11(3):128-35. PubMed ID: 24024573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hantavirus pulmonary syndrome. Pathogenesis of an emerging infectious disease.
    Zaki SR; Greer PW; Coffield LM; Goldsmith CS; Nolte KB; Foucar K; Feddersen RM; Zumwalt RE; Miller GL; Khan AS
    Am J Pathol; 1995 Mar; 146(3):552-79. PubMed ID: 7887439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.